Clinical Highlights: Oral SERDs for Patients With HR+/HER2- ESR1-Mutated Advanced Breast Cancer

Audio podcast with key highlights on current and emerging data for the use of oral SERDS in patients with HR+/HER2- ESR1-mutated advanced breast cancer. Listen to experts put new trial results into context and cover practical perspectives and takeaway points for your everyday practice.